Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer

被引：0
|
作者：
Carraway, H [1 ]
Wolff, AC [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA
来源：
CANCER TREATMENT REVIEWS | 2004年 / 30卷 / 03期
关键词：
D O I：
10.1016/j.ctrv.2004.01.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：303 / 307
页数：5
相关论文
共 50 条
  • [1] Anastrozole - A review of its use in postmenopausal women with early-stage breast cancer
    Sanford, Mark
    Plosker, Greg L.
    [J]. DRUGS, 2008, 68 (09) : 1319 - 1340
  • [2] Anastrozole preferred to tamoxifen for treatment of early-stage breast cancer
    [J]. Nature Clinical Practice Oncology, 2006, 3 (11): : 584 - 585
  • [3] Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer
    Bender, Catherine M.
    Sereika, Susan M.
    Brufsky, Adam M.
    Ryan, Christopher M.
    Vogel, Victor G.
    Rastogi, Priya
    Cohen, Susan M.
    Casillo, Frances E.
    Berga, Sarah L.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 995 - 998
  • [4] Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormonesensitive early-stage breast cancer: a meta-analysis
    Jonat, Walter
    Gnant, Michael
    Boccardo, Francesco
    Kaufmann, Manfred
    Rubagotti, Alessandro
    Zuna, Ivan
    Greenwood, Mike
    Jakesz, Raimund
    [J]. LANCET ONCOLOGY, 2006, 7 (12): : 991 - 996
  • [5] Anastrozole after tamoxifen may benefit women with early breast cancer
    Hayasaka, E
    Zielinski, SL
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) : 1247 - 1247
  • [6] Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer
    Maura K. McCall
    Susan M. Sereika
    Stephanie Snader
    Alexa Lavanchy
    Margaret Q. Rosenzweig
    Yvette P. Conley
    Jan H. Beumer
    Catherine M. Bender
    [J]. Supportive Care in Cancer, 2022, 30 : 9329 - 9340
  • [7] Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer
    McCall, Maura K.
    Sereika, Susan M.
    Snader, Stephanie
    Lavanchy, Alexa
    Rosenzweig, Margaret Q.
    Conley, Yvette P.
    Beumer, Jan H.
    Bender, Catherine M.
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 9329 - 9340
  • [8] A cost-effectiveness analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with early-stage breast cancer in Mexico
    Mould-Quevedo, J.
    Tapia-Valencia, J.
    Davila-Loaiza, G.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A124 - A125
  • [9] Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer
    Needleman, Sarah J.
    Tobias, Jeffrey S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (12) : 1871 - 1881
  • [10] Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer.
    Charlson, J. A.
    Hedin, T.
    Sparapani, R.
    Guo, C.
    Nattinger, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345